Platz Co., Ltd.
Platz Co., Ltd. (7813.T) Stock Competitors & Peer Comparison
See (7813.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 7813.T | ¥838.00 | +0.00% | 2.8B | 15.85 | ¥52.88 | +2.15% |
| 7741.T | ¥27,470.00 | -1.29% | 9.2T | 37.02 | ¥743.06 | +1.07% |
| 4543.T | ¥1,972.50 | -0.83% | 2.9T | 22.11 | ¥88.51 | +1.53% |
| 7733.T | ¥1,571.50 | +0.03% | 1.7T | 17.79 | ¥86.25 | +1.96% |
| 7747.T | ¥3,306.00 | +1.85% | 879B | 50.03 | ¥66.22 | +0.73% |
| 6869.T | ¥1,350.00 | +1.39% | 822B | 17.63 | ¥74.83 | +2.88% |
| 8086.T | ¥1,475.50 | -1.01% | 243.6B | 25.24 | ¥59.17 | +1.87% |
| 7716.T | ¥2,759.00 | -0.93% | 232.4B | -97.56 | -¥28.69 | +1.93% |
| 3360.T | ¥2,266.00 | -1.90% | 208.9B | 14.22 | ¥159.62 | +2.64% |
| 7817.T | ¥3,515.00 | +0.00% | 197.1B | 0.00 | ¥2,596,818,940.00 | +3.16% |
Stock Comparison
7813.T vs 7741.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7741.T has a market cap of 9.2T. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7741.T trades at ¥27,470.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7741.T's P/E ratio is 37.02. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7741.T's ROE of +0.25%. Regarding short-term risk, 7813.T is less volatile compared to 7741.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7741.T's competition here
7813.T vs 4543.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 4543.T has a market cap of 2.9T. Regarding current trading prices, 7813.T is priced at ¥838.00, while 4543.T trades at ¥1,972.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 4543.T's P/E ratio is 22.11. In terms of profitability, 7813.T's ROE is +0.06%, compared to 4543.T's ROE of +0.09%. Regarding short-term risk, 7813.T is less volatile compared to 4543.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 4543.T's competition here
7813.T vs 7733.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7733.T has a market cap of 1.7T. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7733.T trades at ¥1,571.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7733.T's P/E ratio is 17.79. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7733.T's ROE of +0.11%. Regarding short-term risk, 7813.T is less volatile compared to 7733.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7733.T's competition here
7813.T vs 7747.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7747.T has a market cap of 879B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7747.T trades at ¥3,306.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7747.T's P/E ratio is 50.03. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7747.T's ROE of +0.12%. Regarding short-term risk, 7813.T is less volatile compared to 7747.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7747.T's competition here
7813.T vs 6869.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 6869.T has a market cap of 822B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 6869.T trades at ¥1,350.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 6869.T's P/E ratio is 17.63. In terms of profitability, 7813.T's ROE is +0.06%, compared to 6869.T's ROE of +0.09%. Regarding short-term risk, 7813.T is less volatile compared to 6869.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 6869.T's competition here
7813.T vs 8086.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 8086.T has a market cap of 243.6B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 8086.T trades at ¥1,475.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 8086.T's P/E ratio is 25.24. In terms of profitability, 7813.T's ROE is +0.06%, compared to 8086.T's ROE of +0.06%. Regarding short-term risk, 7813.T is less volatile compared to 8086.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 8086.T's competition here
7813.T vs 7716.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7716.T has a market cap of 232.4B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7716.T trades at ¥2,759.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7716.T's P/E ratio is -97.56. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7716.T's ROE of -0.02%. Regarding short-term risk, 7813.T is less volatile compared to 7716.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7716.T's competition here
7813.T vs 3360.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3360.T has a market cap of 208.9B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3360.T trades at ¥2,266.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3360.T's P/E ratio is 14.22. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3360.T's ROE of +0.10%. Regarding short-term risk, 7813.T is less volatile compared to 3360.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 3360.T's competition here
7813.T vs 7817.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7817.T has a market cap of 197.1B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7817.T trades at ¥3,515.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7817.T's P/E ratio is 0.00. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7817.T's ROE of +0.07%. Regarding short-term risk, 7813.T is more volatile compared to 7817.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7813.T.Check 7817.T's competition here
7813.T vs 7730.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7730.T has a market cap of 164.4B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7730.T trades at ¥1,692.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7730.T's P/E ratio is 29.38. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7730.T's ROE of +0.12%. Regarding short-term risk, 7813.T is less volatile compared to 7730.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7730.T's competition here
7813.T vs 3046.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3046.T has a market cap of 153.8B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3046.T trades at ¥6,540.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3046.T's P/E ratio is 19.40. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3046.T's ROE of +0.25%. Regarding short-term risk, 7813.T is less volatile compared to 3046.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 3046.T's competition here
7813.T vs 3593.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3593.T has a market cap of 143.6B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3593.T trades at ¥6,660.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3593.T's P/E ratio is 227.30. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3593.T's ROE of +0.00%. Regarding short-term risk, 7813.T is more volatile compared to 3593.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7813.T.Check 3593.T's competition here
7813.T vs 7780.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7780.T has a market cap of 119.9B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7780.T trades at ¥1,609.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7780.T's P/E ratio is 24.23. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7780.T's ROE of +0.08%. Regarding short-term risk, 7813.T is less volatile compared to 7780.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7780.T's competition here
7813.T vs 7979.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7979.T has a market cap of 58.1B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7979.T trades at ¥1,644.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7979.T's P/E ratio is 12.80. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7979.T's ROE of +0.10%. Regarding short-term risk, 7813.T is less volatile compared to 7979.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7979.T's competition here
7813.T vs 5889.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 5889.T has a market cap of 54B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 5889.T trades at ¥2,247.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 5889.T's P/E ratio is 14.44. In terms of profitability, 7813.T's ROE is +0.06%, compared to 5889.T's ROE of +0.22%. Regarding short-term risk, 7813.T is less volatile compared to 5889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 5889.T's competition here
7813.T vs 368A.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 368A.T has a market cap of 50.7B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 368A.T trades at ¥1,265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 368A.T's P/E ratio is 13.05. In terms of profitability, 7813.T's ROE is +0.06%, compared to 368A.T's ROE of N/A. Regarding short-term risk, 7813.T is less volatile compared to 368A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 368A.T's competition here
7813.T vs 7749.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7749.T has a market cap of 43.1B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7749.T trades at ¥2,975.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7749.T's P/E ratio is 14.14. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7749.T's ROE of +0.07%. Regarding short-term risk, 7813.T is less volatile compared to 7749.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7749.T's competition here
7813.T vs 3154.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3154.T has a market cap of 18.6B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3154.T trades at ¥831.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3154.T's P/E ratio is 13.74. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3154.T's ROE of +0.07%. Regarding short-term risk, 7813.T is less volatile compared to 3154.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 3154.T's competition here
7813.T vs 7743.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7743.T has a market cap of 16.3B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7743.T trades at ¥545.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7743.T's P/E ratio is 11.89. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7743.T's ROE of +0.06%. Regarding short-term risk, 7813.T is less volatile compared to 7743.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7743.T's competition here
7813.T vs 7775.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7775.T has a market cap of 12.8B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7775.T trades at ¥447.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7775.T's P/E ratio is 12.80. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7775.T's ROE of +0.13%. Regarding short-term risk, 7813.T is less volatile compared to 7775.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7775.T's competition here
7813.T vs 3446.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3446.T has a market cap of 11.4B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3446.T trades at ¥1,988.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3446.T's P/E ratio is 125.91. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3446.T's ROE of +0.03%. Regarding short-term risk, 7813.T is less volatile compared to 3446.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 3446.T's competition here
7813.T vs 7702.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7702.T has a market cap of 10.5B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7702.T trades at ¥425.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7702.T's P/E ratio is 66.41. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7702.T's ROE of -0.01%. Regarding short-term risk, 7813.T is less volatile compared to 7702.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7702.T's competition here
7813.T vs 4556.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 4556.T has a market cap of 9.6B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 4556.T trades at ¥2,273.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 4556.T's P/E ratio is 15.99. In terms of profitability, 7813.T's ROE is +0.06%, compared to 4556.T's ROE of +0.09%. Regarding short-term risk, 7813.T is more volatile compared to 4556.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7813.T.Check 4556.T's competition here
7813.T vs 3604.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 3604.T has a market cap of 6.9B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 3604.T trades at ¥1,198.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 3604.T's P/E ratio is 15.04. In terms of profitability, 7813.T's ROE is +0.06%, compared to 3604.T's ROE of +0.05%. Regarding short-term risk, 7813.T is more volatile compared to 3604.T. This indicates potentially higher risk in terms of short-term price fluctuations for 7813.T.Check 3604.T's competition here
7813.T vs 9340.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 9340.T has a market cap of 6.6B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 9340.T trades at ¥679.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 9340.T's P/E ratio is 14.24. In terms of profitability, 7813.T's ROE is +0.06%, compared to 9340.T's ROE of +0.16%. Regarding short-term risk, 7813.T is less volatile compared to 9340.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 9340.T's competition here
7813.T vs 7980.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7980.T has a market cap of 6.4B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7980.T trades at ¥900.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7980.T's P/E ratio is 11.18. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7980.T's ROE of +0.08%. Regarding short-term risk, 7813.T is less volatile compared to 7980.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7980.T's competition here
7813.T vs 7782.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7782.T has a market cap of 2.9B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7782.T trades at ¥440.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7782.T's P/E ratio is 10.88. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7782.T's ROE of +0.10%. Regarding short-term risk, 7813.T is less volatile compared to 7782.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7782.T's competition here
7813.T vs 7090.T Comparison May 2026
7813.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 7813.T stands at 2.8B. In comparison, 7090.T has a market cap of 1.4B. Regarding current trading prices, 7813.T is priced at ¥838.00, while 7090.T trades at ¥932.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
7813.T currently has a P/E ratio of 15.85, whereas 7090.T's P/E ratio is -5.13. In terms of profitability, 7813.T's ROE is +0.06%, compared to 7090.T's ROE of -1.52%. Regarding short-term risk, 7813.T is less volatile compared to 7090.T. This indicates potentially lower risk in terms of short-term price fluctuations for 7813.T.Check 7090.T's competition here